Vadadustat
ATC B03XA · 6 markets · 14 records
AU 4 records · 4 strengths
- 300 mgtabletVAFSEO vadadustat 450 mg tablet blister pack
- 150 mgtabletVAFSEO vadadustat 450 mg tablet blister pack
- 450 mgtabletVAFSEO vadadustat 450 mg tablet blister pack
Records without a stated strength · 1 VAFSEO
US 3 records · 3 strengths
GB 2 records · 2 strengths
TW 2 records · 2 strengths
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 VAFSEO
| Strength / form / release | US | GB | AU | TW | EU |
|---|---|---|---|---|---|
| 300 mg tablet | VAFSEO | VAFSEO | VAFSEO vadadustat 450 mg tablet blister pack | VAFSEO 衛復守錠劑300毫克 | |
| 150 mg tablet | VAFSEO | VAFSEO | VAFSEO vadadustat 450 mg tablet blister pack | VAFSEO 衛復守錠劑150毫克 | |
| 450 mg tablet | VAFSEO | VAFSEO vadadustat 450 mg tablet blister pack | |||
unknown | VAFSEO | VAFSEO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.